Hypertension: A Companion to Braunwald's Heart Disease

Inside Cover
Copyright
Contributors
Foreword
Preface
Braunwald’s Heart Disease Family of Books
Section I: Epidemiology
	Chapter 1: General Population and Global Cardiovascular Risk Prediction
	Chapter 2: Hypertension in Latin/Hispanic Population
	Chapter 3: Hypertension in East Asians and Native Hawaiians
	Chapter 4: Hypertension in South Asians
Section II: Pathophysiology
	Chapter 5: Pathogenesis of Hypertension
	Chapter 6: Genetics of Hypertension
	Chapter 7: Inflammation and Immunity in Hypertension
Section III: Diagnosis and Evaluation
	Chapter 8: The Environment and High Blood Pressure
	Chapter 9: Office Blood Pressure Measurement
	Chapter 10: Home Monitoring of Blood Pressure
	Chapter 11: Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management
	Chapter 12: White-Coat and Masked Hypertension
	Chapter 13: Renovascular Hypertension and Ischemic Nephropathy
	Chapter 14: Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States
	Chapter 15: Secondary Hypertension: Pheochromocytoma and Paraganglioma
	Chapter 16: Secondary Hypertension: Sleep Disturbances Including Sleep Apnea
	Chapter 17: Hypertension in Children: Diagnosis and Treatment
Section IV: Risk Stratification
	Chapter 18: The Natural History of UntreatedHypertension
	Chapter 19: Isolated Systolic Hypertension
	Chapter 20: Assessment of Target Organ Damage
Section V: Antihypertensive Therapy
	Chapter 21: Diet and Blood Pressure
	Chapter 22: Diuretics in Hypertension
	Chapter 23: Peripheral Adrenergic Blockers
	Chapter 24: Renin Angiotensin Aldosterone System Blockers
	Chapter 25: Calcium Channel Blockers
	Chapter 26: Central Sympathetic Agents and Direct Vasodilators
	Chapter 27: Use of Combination Therapies
	Chapter 28: Device Therapies
	Chapter 29: Alternative Approaches for Lowering Blood Pressure
Section VI: Hypertension Management
	Chapter 30: Approach to Difficult to Manage Primary Hypertension
	Chapter 31: Hypertension in Ischemic Heart Disease
	Chapter 32: Heart Failure
	Chapter 33: Hypertension and Chronic Kidney Disease
	Chapter 34: Transplant Hypertension
	Chapter 35: Obesity
	Chapter 36: Cerebrovascular Disease
	Chapter 37: Diabetes Mellitus
	Chapter 38: Dyslipidemia
Section VII: Special Populations and Special Situations
	Chapter 39: Hypertension in Pregnancy
	Chapter 40: Hypertension in Older People
	Chapter 41: Hypertension in African Americans
	Chapter 42: Orthostatic Hypotension
	Chapter 43: Resistant Hypertension
	Chapter 44: Hypertension and the Perioperative Period
	Chapter 45: Aorta and Peripheral Arterial Disease in Hypertension
	Chapter 46: Hypertensive Emergencies and Urgencies
Section VIII: Outcome Trials
	Chapter 47: Meta-Analyses of Blood Pressure Lowering Trials and the Blood Pressure Lowering Treatment Trialists’ Collaboration
Section IX: Hypertension Treatment in the Future
	Chapter 48: Team-Based Care for Hypertension Management
	Chapter 49: Understanding and Improving Medication Adherence
Section X: Guidelines
	Chapter 50: Updated American Heart Association/American College of Cardiology; European Society of Hypertension/International Society of Hypertension Guidelines
	Chapter 51: Putting All Guidelines Into Perspective
Index